Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT06068582
Recruiting
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
Not applicable · Netherlands · 1 site
Registry update: 3 Apr 2025
NCT05776511
Recruiting
Diagnostic Value of eVOG
Not applicable · France · 1 site
Registry update: 16 Jun 2026
NCT07033975
Recruiting
A Specialized Diet for Multiple Sclerosis
Not applicable · Belgium · 1 site
Registry update: 24 Jun 2025
NCT05482906
Recruiting
Common and Specific Information From Neuroimaging and Smartphone
Not applicable · France · 1 site
Registry update: 13 Mar 2026
NCT05834855
Recruiting
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Phase 3 · Netherlands · 1 site
Registry update: 28 Apr 2023
NCT05051618
Recruiting
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 4 Jun 2026
NCT05819008
Recruiting
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Not applicable · Sweden · 1 site
Registry update: 1 Apr 2026
NCT06964581
Recruiting
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
Not applicable · Italy · 1 site
Registry update: 9 May 2025
NCT05395624
Recruiting
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Phase 1/2 · United States · 3 sites
Registry update: 2 May 2025
NCT05539729
Recruiting
Vancomycin Study in Multiple Sclerosis (MS)
Phase 1 · United States · 1 site
Registry update: 28 Sept 2026
NCT05634967
Recruiting
Kesimpta (Ofatumumab) Pregnancy Registry
Not applicable · United States · 1 site
Registry update: 14 Jan 2025
NCT05433103
Recruiting
Blood Flow Restriction And Veterans With MS
Not applicable · United States · 1 site
Registry update: 23 Feb 2026
NCT05735691
Recruiting
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
Not applicable · United States · 2 sites
Registry update: 5 Jun 2024
NCT05418010
Recruiting
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)
Phase 2 · United Kingdom · 2 sites
Registry update: 7 Jan 2026
NCT05092191
Recruiting
Cannabis as a Complementary Treatment in Multiple Sclerosis
Phase 2 · Canada · 1 site
Registry update: 13 Dec 2024
NCT06203106
Recruiting
NYSCF Scientific Discovery Biobank
Not applicable · United States · 1 site
Registry update: 3 Mar 2025
NCT05961644
Recruiting
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Phase 2/3 · Poland · 2 sites
Registry update: 28 Jul 2023
Conflicting statuses (not updated in the registry for 39 months)
NCT05123443
Recruiting
Longitudinal Assessment of Iron Rims in MS Lesions
Not applicable · United Kingdom · 1 site
Registry update: 12 Mar 2026
NCT06267781
Recruiting
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
Not applicable · Italy · 1 site
Registry update: 20 Feb 2024
NCT05355389
Recruiting
Cognitive-motor Telerehabilitation in MS
Not applicable · Belgium · 2 sites
Registry update: 8 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.